Efficacy and Tolerability of Lisdexamfetamine as an Antidepressant Augmentation Strategy: A Meta-Analysis of Randomized Controlled Trials

Psychostimulants have been used in the treatment of depression, with mixed results. This meta-analysis examines the efficacy and tolerability of the stimulant Lisdexamfetamine (LDX) as an add-on strategy in those with MDD who have failed to respond to an antidepressant.

Source: Journal of Affective Disorders - October 3, 2017 Category: Neurology Authors: Peter Giacobbe, Uros Rakita, Raymond Lam, Roumen Milev, Sidney H. Kennedy, Roger S. McIntyre Tags: Research paper Source Type: research